These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 21802498)
61. Central nervous system sulfatide deficiency as a causal factor for bladder disorder in Alzheimer's disease. He S; Qiu S; Pan M; Palavicini JP; Wang H; Li X; Bhattacharjee A; Barannikov S; Bieniek KF; Dupree JL; Han X Clin Transl Med; 2023 Jul; 13(7):e1332. PubMed ID: 37478300 [TBL] [Abstract][Full Text] [Related]
62. Mass and relative elution time profiling: two-dimensional analysis of sphingolipids in Alzheimer's disease brains. Hejazi L; Wong JW; Cheng D; Proschogo N; Ebrahimi D; Garner B; Don AS Biochem J; 2011 Aug; 438(1):165-75. PubMed ID: 21639855 [TBL] [Abstract][Full Text] [Related]
63. Specific changes of sulfatide levels in individuals with pre-clinical Alzheimer's disease: an early event in disease pathogenesis. Cheng H; Wang M; Li JL; Cairns NJ; Han X J Neurochem; 2013 Dec; 127(6):733-8. PubMed ID: 23865640 [TBL] [Abstract][Full Text] [Related]
64. A novel method for the measurement of in vitro fatty acid 2-hydroxylase activity by gas chromatography-mass spectrometry. Alderson NL; Walla MD; Hama H J Lipid Res; 2005 Jul; 46(7):1569-75. PubMed ID: 15863841 [TBL] [Abstract][Full Text] [Related]
65. 2-Hydroxylated sphingomyelin profiles in cells from patients with mutated fatty acid 2-hydroxylase. Dan P; Edvardson S; Bielawski J; Hama H; Saada A Lipids Health Dis; 2011 May; 10():84. PubMed ID: 21599921 [TBL] [Abstract][Full Text] [Related]
66. Early glycolipid (POA) in pro-oligodendroblasts revealed to be sulfatide: An Editorial Highlight for 'Sulfatide species with various fatty acid chains in oligodendrocytes at different developmental stages determined by imaging mass spectrometry'. Boggs JM J Neurochem; 2017 Feb; 140(3):356-358. PubMed ID: 27976382 [TBL] [Abstract][Full Text] [Related]
67. Unraveling the complexity of glycosphingolipidome: the key role of mass spectrometry in the structural analysis of glycosphingolipids. Hořejší K; Holčapek M Anal Bioanal Chem; 2024 Oct; 416(25):5403-5421. PubMed ID: 39138658 [TBL] [Abstract][Full Text] [Related]
68. Spatial lipidomics reveals brain region-specific changes of sulfatides in an experimental MPTP Parkinson's disease primate model. Kaya I; Nilsson A; Luptáková D; He Y; Vallianatou T; Bjärterot P; Svenningsson P; Bezard E; Andrén PE NPJ Parkinsons Dis; 2023 Jul; 9(1):118. PubMed ID: 37495571 [TBL] [Abstract][Full Text] [Related]
69. Fatty Acid 2-Hydroxylase and 2-Hydroxylated Sphingolipids: Metabolism and Function in Health and Diseases. Eckhardt M Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902339 [TBL] [Abstract][Full Text] [Related]
70. The repertoire of protein-sulfatide interactions reveal distinct modes of sulfatide recognition. Capelluto DGS Front Mol Biosci; 2022; 9():1080161. PubMed ID: 36533082 [TBL] [Abstract][Full Text] [Related]
71. Comprehensive Identification of Glycosphingolipids in Human Plasma Using Hydrophilic Interaction Liquid Chromatography-Electrospray Ionization Mass Spectrometry. Hořejší K; Jirásko R; Chocholoušková M; Wolrab D; Kahoun D; Holčapek M Metabolites; 2021 Feb; 11(3):. PubMed ID: 33652716 [TBL] [Abstract][Full Text] [Related]
72. Molecular composition of the human primary visual cortex profiled by multimodal mass spectrometry imaging. González de San Román E; Bidmon HJ; Malisic M; Susnea I; Küppers A; Hübbers R; Wree A; Nischwitz V; Amunts K; Huesgen PF Brain Struct Funct; 2018 Jul; 223(6):2767-2783. PubMed ID: 29633039 [TBL] [Abstract][Full Text] [Related]
73. Progressive white matter atrophy with altered lipid profiles is partially reversed by short-term abstinence in an experimental model of alcohol-related neurodegeneration. Yalcin EB; McLean T; Tong M; de la Monte SM Alcohol; 2017 Dec; 65():51-62. PubMed ID: 29084630 [TBL] [Abstract][Full Text] [Related]
74. High-throughput analysis of sulfatides in cerebrospinal fluid using automated extraction and UPLC-MS/MS. Blomqvist M; Borén J; Zetterberg H; Blennow K; Månsson JE; Ståhlman M J Lipid Res; 2017 Jul; 58(7):1482-1489. PubMed ID: 28550076 [TBL] [Abstract][Full Text] [Related]
75. Hippocampal lipid differences in Alzheimer's disease: a human brain study using matrix-assisted laser desorption/ionization-imaging mass spectrometry. Mendis LH; Grey AC; Faull RL; Curtis MA Brain Behav; 2016 Oct; 6(10):e00517. PubMed ID: 27781133 [TBL] [Abstract][Full Text] [Related]
76. The Role of 3-O-Sulfogalactosylceramide, Sulfatide, in the Lateral Organization of Myelin Membrane. Grassi S; Prioni S; Cabitta L; Aureli M; Sonnino S; Prinetti A Neurochem Res; 2016 Feb; 41(1-2):130-43. PubMed ID: 26542149 [TBL] [Abstract][Full Text] [Related]
77. Global changes of phospholipids identified by MALDI imaging mass spectrometry in a mouse model of Alzheimer's disease. Hong JH; Kang JW; Kim DK; Baik SH; Kim KH; Shanta SR; Jung JH; Mook-Jung I; Kim KP J Lipid Res; 2016 Jan; 57(1):36-45. PubMed ID: 26538545 [TBL] [Abstract][Full Text] [Related]
78. A review of odd-chain fatty acid metabolism and the role of pentadecanoic Acid (c15:0) and heptadecanoic Acid (c17:0) in health and disease. Jenkins B; West JA; Koulman A Molecules; 2015 Jan; 20(2):2425-44. PubMed ID: 25647578 [TBL] [Abstract][Full Text] [Related]
79. Quantitative imaging mass spectrometry of renal sulfatides: validation by classical mass spectrometric methods. Marsching C; Jennemann R; Heilig R; Gröne HJ; Hopf C; Sandhoff R J Lipid Res; 2014 Nov; 55(11):2343-53. PubMed ID: 25274613 [TBL] [Abstract][Full Text] [Related]